Effects of Naproxen on Physical Performance

This study has been terminated.
(Study never initiated.)
Information provided by:
University of Oklahoma
ClinicalTrials.gov Identifier:
First received: December 12, 2006
Last updated: October 10, 2007
Last verified: October 2007
The purpose of this study is to determine the effect of daily use of Naproxen (a commonly used over-the-counter NSAID) on the physical performance of athletes, as measured by maximum oxygen consumption.

Condition Intervention Phase
Drug: Naproxen
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effects of Naproxen on Physical Performance

Resource links provided by NLM:

Further study details as provided by University of Oklahoma:

Primary Outcome Measures:
  • Effects on physical performance in terms of maximum oxygen consumption

Estimated Enrollment: 40
Study Start Date: May 2004
Study Completion Date: August 2006

Ages Eligible for Study:   18 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  1. Age equal to or greater than18 years of age
  2. No history of allergy or adverse reaction to any NSAID
  3. No use of any NSAID in past 2 weeks
  4. No history of peptic ulcer disease (PUD), gastroesophageal disease (GERD), or gastritis
  5. No major medical history including but not limited to diabetes, hypertension, asthma, kidney disease and coronary artery disease
  6. Currently not taking any medication including oral contraceptives

Exclusion Criteria:

  1. Age < 18 years of age
  2. History of allergy or adverse reaction to any NSAID
  3. Use of any NSAID in past 2 weeks
  4. History of a bleeding disorder
  5. History of PUD, GERD, or gastritis
  6. Pregnant
  7. A medical history of diabetes, hypertension, asthma, kidney disease or coronary artery disease
  8. Taking any medication including oral contraceptives
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00410995

United States, Oklahoma
Family Practice - CMT
Tulsa, Oklahoma, United States, 74104
Sponsors and Collaborators
University of Oklahoma
Principal Investigator: LaMont Cavanagh, MD University of Oklahoma-Tulsa
  More Information

ClinicalTrials.gov Identifier: NCT00410995     History of Changes
Other Study ID Numbers: 11186 
Study First Received: December 12, 2006
Last Updated: October 10, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of Oklahoma:
Physically fit volunteers

Additional relevant MeSH terms:
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Gout Suppressants
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Physiological Effects of Drugs
Sensory System Agents

ClinicalTrials.gov processed this record on May 26, 2016